FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034657211> ?p ?o ?g. }

• W2034657211 endingPage "1078" @default.
• W2034657211 startingPage "1067" @default.
• W2034657211 abstract "Since 1969, 184 previously untreated and evaluable adult patients with Hodgkin's disease, staged as I (43) or II (141), have been treated. Eighty patients were part of the National Hodgkin's Disease Study, randomly assigned to receive radiotherapy to either an involved (39) or extended field (41). In a subsequent single-arm study, 104 patients were treated with involved-field radiotherapy preceded and followed by three cycles of MOPP chemotherapy. Median durations of follow-up have been 172, 172, and 92 months, for the involved-field radiotherapy, extended-field radiotherapy, and MOPP plus involved-field radiotherapy treatment groups, respectively. Although significant differences among the three treatment groups were observed with respect to disease-free survival (p less than 0.001), only the group of patients treated with involved-field radiotherapy had a statistically significant decline in overall survival as compared with the two other treatment groups (p less than 0.001). Moreover, patients who underwent clinical staging and were treated with MOPP plus involved-field radiotherapy had significantly prolonged disease-free survival compared with those who underwent surgical staging and were treated with extended-field radiotherapy (p less than 0.001). One of the patients who received MOPP plus involved-field radiotherapy had subsequent development of acute monocytic leukemia, and another had refractory anemia with excess blasts. One instance of diffuse poorly differentiated lymphocytic lymphoma was also observed. Acute monocytic leukemia developed in another patient treated with involved-field radiotherapy. The rates of amenorrhea in the group treated with MOPP plus involved-field radio-therapy were 9.6 percent and 78.5 percent for female patients younger and older than 30 years of age, respectively. Despite the universal azoospermia ensuing after MOPP plus involved-field radiotherapy, in three patients whose sperm counts were checked sequentially for 26 to 53 months after treatment, evidence of spermatogenesis was observed. Three patients with remission of Hodgkin's disease after involved-field (two) and extended-field (one) radiotherapy died from cardiovascular disease that could only be attributed to the prior radiotherapy. Although further follow-up evaluation will be required to determine the impact of the three different treatment modalities on survival and long-term toxicity, MOPP plus involved-field radiotherapy appears to be superior to involved-field or extended-field radiotherapy alone in achieving prolonged disease-free survival without significant leukemogenic potential." @default.
• W2034657211 created "2016-06-24" @default.
• W2034657211 creator A5001268619 @default.
• W2034657211 creator A5006117950 @default.
• W2034657211 creator A5011131759 @default.
• W2034657211 creator A5014561472 @default.
• W2034657211 creator A5019450311 @default.
• W2034657211 creator A5025381409 @default.
• W2034657211 creator A5027829771 @default.
• W2034657211 creator A5029382428 @default.
• W2034657211 creator A5032257865 @default.
• W2034657211 creator A5075942283 @default.
• W2034657211 creator A5078657886 @default.
• W2034657211 creator A5082920254 @default.
• W2034657211 creator A5087581069 @default.
• W2034657211 creator A5087914424 @default.
• W2034657211 date "1986-06-01" @default.
• W2034657211 modified "2023-09-24" @default.
• W2034657211 title "Treatment of stages I and II hodgkin's disease with three different therapeutic modalities" @default.
• W2034657211 cites W1523144738 @default.
• W2034657211 cites W1545719768 @default.
• W2034657211 cites W1555511702 @default.
• W2034657211 cites W1965965711 @default.
• W2034657211 cites W1979128420 @default.
• W2034657211 cites W1984458188 @default.
• W2034657211 cites W2009608385 @default.
• W2034657211 cites W2011982330 @default.
• W2034657211 cites W2012582720 @default.
• W2034657211 cites W2021616554 @default.
• W2034657211 cites W2021699851 @default.
• W2034657211 cites W2026105570 @default.
• W2034657211 cites W2033029242 @default.
• W2034657211 cites W2043860295 @default.
• W2034657211 cites W2051909027 @default.
• W2034657211 cites W2052948151 @default.
• W2034657211 cites W2058655763 @default.
• W2034657211 cites W2061815025 @default.
• W2034657211 cites W2068738108 @default.
• W2034657211 cites W2073205845 @default.
• W2034657211 cites W2087621675 @default.
• W2034657211 cites W2092015388 @default.
• W2034657211 cites W2092248185 @default.
• W2034657211 cites W2171843975 @default.
• W2034657211 cites W2246556650 @default.
• W2034657211 cites W2341378641 @default.
• W2034657211 cites W2398325430 @default.
• W2034657211 cites W2407048583 @default.
• W2034657211 cites W2408324020 @default.
• W2034657211 cites W2573242028 @default.
• W2034657211 cites W3024581602 @default.
• W2034657211 cites W4293241248 @default.
• W2034657211 cites W4298434897 @default.
• W2034657211 doi "https://doi.org/10.1016/0002-9343(86)90667-4" @default.
• W2034657211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3755285" @default.
• W2034657211 hasPublicationYear "1986" @default.
• W2034657211 type Work @default.
• W2034657211 sameAs 2034657211 @default.
• W2034657211 citedByCount "33" @default.
• W2034657211 countsByYear W20346572112015 @default.
• W2034657211 countsByYear W20346572112023 @default.
• W2034657211 crossrefType "journal-article" @default.
• W2034657211 hasAuthorship W2034657211A5001268619 @default.
• W2034657211 hasAuthorship W2034657211A5006117950 @default.
• W2034657211 hasAuthorship W2034657211A5011131759 @default.
• W2034657211 hasAuthorship W2034657211A5014561472 @default.
• W2034657211 hasAuthorship W2034657211A5019450311 @default.
• W2034657211 hasAuthorship W2034657211A5025381409 @default.
• W2034657211 hasAuthorship W2034657211A5027829771 @default.
• W2034657211 hasAuthorship W2034657211A5029382428 @default.
• W2034657211 hasAuthorship W2034657211A5032257865 @default.
• W2034657211 hasAuthorship W2034657211A5075942283 @default.
• W2034657211 hasAuthorship W2034657211A5078657886 @default.
• W2034657211 hasAuthorship W2034657211A5082920254 @default.
• W2034657211 hasAuthorship W2034657211A5087581069 @default.
• W2034657211 hasAuthorship W2034657211A5087914424 @default.
• W2034657211 hasConcept C126322002 @default.
• W2034657211 hasConcept C141071460 @default.
• W2034657211 hasConcept C2776694085 @default.
• W2034657211 hasConcept C2779134260 @default.
• W2034657211 hasConcept C509974204 @default.
• W2034657211 hasConcept C71924100 @default.
• W2034657211 hasConcept C90924648 @default.
• W2034657211 hasConceptScore W2034657211C126322002 @default.
• W2034657211 hasConceptScore W2034657211C141071460 @default.
• W2034657211 hasConceptScore W2034657211C2776694085 @default.
• W2034657211 hasConceptScore W2034657211C2779134260 @default.
• W2034657211 hasConceptScore W2034657211C509974204 @default.
• W2034657211 hasConceptScore W2034657211C71924100 @default.
• W2034657211 hasConceptScore W2034657211C90924648 @default.
• W2034657211 hasIssue "6" @default.
• W2034657211 hasLocation W20346572111 @default.
• W2034657211 hasLocation W20346572112 @default.
• W2034657211 hasOpenAccess W2034657211 @default.
• W2034657211 hasPrimaryLocation W20346572111 @default.
• W2034657211 hasRelatedWork W2002120878 @default.
• W2034657211 hasRelatedWork W2003938723 @default.
• W2034657211 hasRelatedWork W2047967234 @default.
• W2034657211 hasRelatedWork W2118496982 @default.

• next